drugset / Trial / NCT01016977
A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris
RandomizedParallel-groupSingle-blindTreatment
Summary
A single-blind (investigator-blinded), randomized, parallel group, single center study to evaluate the tolerability and efficacy of combination therapy with Duac Gel / 0.1% Tazorac Cream and Acanya Gel / 0.1% Tazorac Cream for the treatment of facial acne vulgaris.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CLNP-BPO2.5 | Unknown | 1.2 % | Topical |
| Comparator | CLNP-BPO2.5 | Unknown | 2.5 % | Topical |
| Comparator | CLNP-BPO5 | Unknown | 1 % | Topical |
| Comparator | CLNP-BPO5 | Unknown | 5 % | Topical |
| Comparator | Tazarotene | Small molecule | 0.1 % | Topical |